Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate Cancer
Yaru Xu, Yuqiu Yang, Zhaoning Wang, et al.
Cancer Discovery (2024) Vol. 14, Iss. 8, pp. 1496-1521
Open Access | Times Cited: 11

Showing 11 citing articles:

Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 25
Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance
Caihong Li, Dongkai Cheng, Peng Li
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1
Dna-Methylation Eraser Tet2 Activates Wtip Expression to Suppress an Akt-Dependent Chemoresistance of Gastric Cancer
Yan Guo, Hongyang Yu, Jinyang Li, et al.
(2025)
Closed Access
The Warburg effect: the hacked mitochondrial-nuclear communication in cancer
Haowen Jiang, Jiangbin Ye
Seminars in Cancer Biology (2025)
Closed Access
DNA-methylation eraser TET2 activates WTIP expression to suppress an AKT-dependent chemoresistance of gastric cancer
Yan Guo, Hongyang Yu, Jinyang Li, et al.
Neoplasia (2025) Vol. 65, pp. 101166-101166
Closed Access
FOXA1-dependent NSUN2 facilitates the advancement of prostate cancer by preserving TRIM28 mRNA stability in a m5C-dependent manner
Zhenda Wang, Mierxiati Abudurexiti, Wenkai Zhu, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Treatment-induced stemness and lineage plasticity in driving prostate cancer therapy resistance
Anmbreen Jamroze, Xiaozhuo Liu, Dean G. Tang
(2024), pp. 1-35
Open Access | Times Cited: 2
Integrative analysis identifies the atypical repressor E2F8 as a targetable transcriptional activator driving lethal prostate cancer
Furong Huang, Kexin Li, Zhong Chen, et al.
Oncogene (2024)
Closed Access | Times Cited: 1
Restoring our ubiquitination machinery to overcome resistance in cancer therapy
Xiaoling Li, Ping Mu
Oncoscience (2024) Vol. 11, pp. 43-44
Open Access
Neuroendocrine transdifferentiation in human cancer: molecular mechanisms and therapeutic targets
Jun Jiang, Donghui Han, Jiawei Wang, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access
Personalized Medicine: Leave no Patient Behind; Report From the 2024 Coffey‐Holden Prostate Cancer Academy Meeting
Andrea K. Miyahira, Marina N. Sharifi, Lisa N. Chesner, et al.
The Prostate (2024) Vol. 85, Iss. 3, pp. 211-226
Closed Access
Epigenetic regulation of nuclear receptors: Implications for endocrine-related diseases and therapeutic strategies
Yixin Song, Kexin Zhang, Jingwen Zhang, et al.
Genes & Diseases (2024) Vol. 12, Iss. 4, pp. 101481-101481
Open Access
Page 1

Scroll to top